Tarsus issues 'call to action' months before FDA decision on eye mite treatment

2023-05-09

上市批准

Tarsus Pharmaceuticals has a message for patients who think they may have Demodex blepharitis or irritated eyes caused by tiny mites: “Don’t freak out. Get checked out.” The new unbranded campaign launched on Monday, just a few months before the FDA is expected to make a decision on Tarsus’ treatment, a version of the common veterinary drug lotilaner used to prevent tick and flea infestations in dogs. An approval would mark the first time the drug has been cleared for humans. While Tarsus’ last campaign , “Look at the Lids,” targeted eyecare professionals, this one aims to educate patients about the symptoms and diagnosis of Demodex blepharitis.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构